Why is DR Horton stock sliding today?

DR Horton stock is sliding 3.1% in pre-open trading after the homebuilder reported fiscal fourth-quarter results this morning that badly missed Wall Street’s earnings expectations.

The company delivered adjusted EPS of $2.67, a $0.34 shortfall versus the analyst consensus of $3.01, while net income fell 18% year-over-year to $741.8 million — a result that included $91.4 million in inventory impairment charges tied to its rental segment and a pre-tax profit margin of just 10.8%, well below the company’s own guided range of 12.3%–12.8%.

On the revenue side, DR Horton did manage to exceed expectations, posting $9.4 billion against a consensus estimate of $9.07 billion, but the top-line beat was insufficient to offset investor concern over margin deterioration. Demand conditions remained strained, with the cancellation rate rising to 20% from 17% a year earlier, reflecting the persistent grip of elevated mortgage rates and affordability pressures on prospective buyers.

Adding to the negative backdrop, the stock had accumulated 14 negative EPS revisions and zero positive revisions in the 90 days leading up to today’s report, signaling that analysts had already grown cautious — yet the actual results still came in below even those reduced expectations.

The broader market offered little support, with the S&P 500 slipping 0.1% and the Nasdaq declining 0.8% in today’s session, leaving no macro tailwind to cushion the stock’s move. Several major Wall Street firms had already trimmed their price targets on DHI in the weeks prior — including Keefe Bruyette (to $152), Wells Fargo (to $140), Citi (to $150), and Barclays (to $130) — reflecting a sector-wide reassessment of homebuilder profitability amid sustained affordability headwinds and elevated incentive spending.

Taken together, the sharp earnings miss, the rental segment impairment, a deteriorating cancellation rate, and a pre-existing wall of analyst skepticism combined to push DR Horton shares toward the lower end of their 52-week range of $130.40–$170.78, as investors reassess the pace at which margin recovery can materialize in a still-challenging housing environment.